Circadian patterns of plasma t-PA and PAI-1 antigen levels in patients with severe peripheral atherosclerosis

Fibrinolysis

Volumn 10, Issue SUPPL. 2, 1996, Pages 159-160

  Andreotti, F ^a   Prevost, R ^b   Lupi, A ^a   Hamilton, J ^a   De Bart, A C W ^b   Huisman, L G M ^b   Maseri, A ^a   Kluft, C ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b TNO   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR;

ATHEROSCLEROSIS; BLOOD LEVEL; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL;

EID: 0029911983     PISSN: 02689499     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0268-9499(96)80076-2     Document Type: Conference Paper

References (4)

1. Hamsten A, de Faire U, Walldius G et al. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet 1987; ii:3-9.
2. Thompson SG, Kienast J, Pyke SDM, Haverkate F, van de Loo JCW. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N EnglJMed 1995; 332:635-41.
3. Andreotti F, Kluft C, Davies GJ, Huisman LGM, de Bart ACW, Maseri A. Effect of propranolol (long-acting) on the circadian fluctuation of tissue-type plasminogen activator and plasminogen activator inhibitor-1. Am J Cardiol 1991; 68: 1295-9.
4. Chandler WL, Trimble SL, Loo SC, Mornin D. Effects of PAI-1 levels on the molar concentrations of active tissue plasminogen activator (t-PA) and t-PA/PAI-1 complex in plasma. Blood 1990; 76:930-7.